What Causes Anxiety? The Biology and Environment Behind It
Reviewed byElizabeth Lokenauth, PA-C
SiggyMD Clinical Team · Last updated June 25, 2026
Key Takeaways
- Anxiety disorders affect 19.1% of U.S. adults in any given year, making them the most prevalent class of mental health conditions. They are not a character trait or a choice; they result from measurable biological changes in how the brain processes threat.
- The amygdala is the brain's primary threat-detection center. In anxiety disorders, the amygdala shows hyperactivity, producing exaggerated fear responses and heightened sensitivity to potential threats. The prefrontal cortex, which normally regulates the amygdala's response, shows reduced inhibitory control in anxiety.
- The hypothalamic-pituitary-adrenal (HPA) axis governs the body's stress response, releasing cortisol in response to threat. Chronic dysregulation of the HPA axis, often from sustained stress or early life adversity, alters amygdala volume, hippocampal function, and prefrontal cortex activity, creating biological vulnerability to anxiety disorders.
- GABA, the brain's primary inhibitory neurotransmitter, and norepinephrine, the primary stress-response neurotransmitter, are both implicated in anxiety disorders. Benzodiazepines work by enhancing GABA; SSRIs and SNRIs address serotonergic and noradrenergic dysregulation upstream.
- Genetic factors account for approximately 30 to 50 percent of anxiety disorder risk. Early life stress, trauma, and environmental adversity interact with genetic vulnerability through epigenetic mechanisms, permanently altering HPA axis function and amygdala reactivity.
Anxiety has a reputation for being something people should just push through. That framing misses what anxiety actually is at the biological level.
Anxiety disorders affect 19.1% of U.S. adults in the past year, making them the most prevalent class of mental health conditions. They are not the result of excessive worry, weakness, or poor coping. They are the result of specific measurable changes in how the brain processes and responds to threat.
Understanding what actually drives anxiety, which brain structures are involved, and what biological systems are dysregulated, gives patients and clinicians a better foundation for treatment. It also explains why effective treatments work.
What This Page Covers
- The amygdala’s role in anxiety and why it becomes hyperactive
- The HPA axis and how chronic stress reshapes threat response
- GABA, norepinephrine, and serotonin: the neurotransmitter systems implicated
- Genetic factors in anxiety risk
- How environmental stressors interact with biology
- Why effective treatments target these systems
- How ongoing monitoring changes outcomes for anxiety disorders
The Amygdala: The Brain’s Threat Detection Center
The amygdala is an almond-shaped structure in the medial temporal lobe. Its core function is evaluating sensory information for potential threat and initiating the appropriate biological response. It operates fast, typically before conscious awareness, which is why anxiety responses can feel automatic and outside of voluntary control.
Hyperactivity in the amygdala is commonly observed in individuals with anxiety disorders, leading to exaggerated fear responses and heightened sensitivity to potential threats. In someone with generalized anxiety disorder, the amygdala treats ambiguous or neutral stimuli as threatening. In panic disorder, it can generate the full physiological cascade of danger response in the absence of any objective threat.
The prefrontal cortex normally exerts top-down inhibitory control over the amygdala, regulating the intensity and duration of fear responses. In anxiety disorders, dysfunction in the PFC results in impaired regulation of fear and anxiety, leading to persistent worry and rumination. The amygdala activates; the PFC cannot turn it down.
This circuit, hyperactive amygdala and underactive prefrontal regulation, is a consistent neurobiological signature across anxiety disorders. It is visible on functional MRI and has been replicated across multiple independent research groups.
The HPA Axis: How Stress Becomes Biological
The hypothalamic-pituitary-adrenal axis governs the body’s stress response. When a threat is perceived, the hypothalamus releases corticotropin releasing hormone (CRH), which travels to the pituitary, which releases adrenocorticotrophic hormone (ACTH), which stimulates the adrenal glands to release cortisol. Cortisol mobilizes energy, sharpens attention, and prepares the body to respond to threat.
Under normal conditions, cortisol feeds back to inhibit further CRH and ACTH release, returning the system to baseline. Under conditions of chronic stress, this mechanism can break down, generating hyperactivity of the HPA axis, often associated with anxiety and contributing to symptoms such as irritability, difficulty concentrating, and fatigue.
Sustained HPA hyperactivity does structural damage. Prolonged exposure to elevated cortisol can damage the hippocampus, critical for memory and learning, and can cause the amygdala, involved in emotional processing, to become hyperactive, exacerbating symptoms of anxiety and emotional reactivity.
This is why chronic life stress, if sustained long enough, changes the biology of threat processing rather than just representing an emotional response to circumstances.
Early Life Adversity: When the Biology Is Set Early
The brain develops most rapidly during childhood, making it particularly vulnerable to the effects of environmental stressors during that period.
Early-life stress, such as childhood trauma or neglect, has a lasting impact on brain development and function, increasing the risk of anxiety disorders later in life. These changes occur through epigenetic mechanisms: DNA methylation, altered microRNA expression, and modified gene expression patterns that affect how stress-response genes are regulated. These changes can persist across decades.
Amygdala functional connectivity longitudinally predicted anxiety symptoms and emotion regulation skills at later follow-up, confirming that the structural and functional differences in anxiety disorders are not just correlates of current distress but predictors of future vulnerability.
Neurotransmitter Systems: GABA, Norepinephrine, and Serotonin
Three neurotransmitter systems are consistently implicated in anxiety disorders.
GABA
GABA is the brain’s primary inhibitory neurotransmitter. It reduces neuronal excitability throughout the nervous system, producing a calming effect on anxiety circuits. Benzodiazepines potentiate the CNS inhibitory effects of endogenous GABA by allosteric modulation of the GABA-A receptor, which explains both their rapid anxiolytic effect and their risk of dependence. People with anxiety disorders often show reduced GABA activity in key brain regions, contributing to heightened arousal and difficulty turning off the stress response.
Norepinephrine
Norepinephrine is released from the locus coeruleus in response to stress and threat. It increases heart rate, blood pressure, and alertness, preparing the body for the fight-or-flight response. In anxiety disorders, the norepinephrine system can be chronically overactive, producing persistent hyperarousal, exaggerated startle responses, and physical symptoms like trembling, sweating, and racing heart. SNRIs address this system by blocking the norepinephrine transporter in addition to SERT.
Serotonin
Serotonin pathways project widely through the brain, including to the amygdala, prefrontal cortex, and hippocampus. The serotonergic innervation to the amygdala is influenced by SSRIs and leads to positive shifts in the way the brain appraises emotionally-valenced information, with this effect occurring very early in treatment, prior to clinical antidepressant effects. This serotonin-amygdala pathway helps explain why SSRIs reduce anxiety over several weeks: they shift how the brain evaluates threat.
Genetic Factors in Anxiety Risk
Anxiety disorders run in families. Twin studies consistently show that genetic factors and individual environmental factors, such as stressful life events, are among the most potent predictors of anxiety onset, with heritability estimates ranging from approximately 30 to 50 percent depending on the specific disorder.
Genetic risk is mediated through specific biological mechanisms. Genetic variants influencing the HPA axis and the serotonin transporter gene (5-HTTLPR) affect amygdala connectivity and stress reactivity. Individuals carrying risk variants tend to have weaker connectivity between the amygdala and regulatory prefrontal regions, producing less top-down inhibitory control.
Importantly, genetic predispositions and individual environmental factors interact to predict disorders. Genetic vulnerability does not cause anxiety disorders in isolation; it produces biological sensitivity that, in the presence of relevant environmental stressors, increases the likelihood of a clinical disorder developing.
Environmental Triggers: What Activates the Biology
Specific life circumstances activate underlying biological vulnerability. The most potent environmental risk factors for anxiety disorders include:
Chronic stress: Sustained occupational, financial, or relational stress maintains HPA axis activation beyond adaptive levels, gradually reshaping the biology of threat response.
Childhood adversity: Early life trauma has the strongest and most lasting environmental impact on anxiety risk, altering both structure and function in the anxiety circuitry.
Major life transitions: Loss, separation, job change, medical illness, and other significant disruptions increase the demand placed on regulatory systems, sometimes exceeding their capacity.
Substance and alcohol use: Alcohol temporarily suppresses anxiety through GABA enhancement but produces rebound anxiety during withdrawal. Chronic alcohol use disrupts GABA receptors, paradoxically worsening anxiety over time.
Why Effective Treatments Work
Understanding the biology of anxiety explains why evidence-based treatments produce measurable changes.
SSRIs and SNRIs gradually shift amygdala threat appraisal by modulating serotonin and norepinephrine pathways. This is why they take 4 to 6 weeks, rather than hours: the relevant changes are neuroplastic adaptations in receptor sensitivity and downstream signaling, not immediate chemistry.
Cognitive behavioral therapy (CBT) directly strengthens prefrontal cortex regulation of the amygdala. Repeated exposure to feared stimuli in a controlled context allows fear extinction: the amygdala learns, through practice, that the threat signal is false. This is a biological change mediated by the same amygdala-prefrontal circuitry that is disrupted in anxiety disorders.
Combined medication and therapy consistently outperforms either alone, because they address the biological and regulatory dimensions of the disorder through complementary mechanisms.
About SiggyMD
Anxiety disorders have effective treatments. The gap between available treatments and patient outcomes comes down to access, monitoring, and the space between appointments.
SiggyMD provides clinician-reviewed medication care for anxiety, with daily check-ins that track symptom trajectory, medication adherence, and side effects in real time. A licensed prescriber reviews every clinical decision. The anonymous intake requires no account, name, or email to begin.
“Anxiety has a biology,” says Elizabeth Lokenauth, PA-C, of the SiggyMD clinical team. “Patients often come in describing their anxiety as a failure of willpower or a personality flaw. What’s actually happening is their amygdala is hyperactive and their prefrontal cortex isn’t providing enough inhibitory control. That’s a biological pattern with biological treatments. Understanding that helps people stay in care.”
For more on what anxiety medications are available and how they compare, read our guide to anxiety medication options and side effect profiles.
Start your anonymous intake with SiggyMD to speak with a licensed prescriber who understands the clinical picture.
What Members Are Saying
TL
T.L., 36
Generalized Anxiety Disorder
“No one had ever explained to me that my anxiety was happening in my brain physically, not just emotionally. When my prescriber showed me how the amygdala and stress response work, I finally understood why the medication needed weeks to help and why it worked. That explanation made me patient enough to stay on it.”
WM
W.M., 28
Social Anxiety Disorder
“I spent years thinking I was just shy or awkward. Understanding that what I was dealing with was a real disorder with real biology made me take treatment seriously. The daily check-in means I don’t have to wait three months to tell someone I’m struggling.”
Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary.
Sources
-
National Institute of Mental Health. Any Anxiety Disorder. NIMH. Accessed June 2026.
-
Open Access Journals. The Neurobiology of Anxiety Disorders. NPOA. October 2024.
-
Garakani A, et al. Pharmacotherapy for Anxiety Disorders: From First-Line Options to Treatment Resistance. Frontiers in Psychiatry. 2021;11:595584.
-
Pagliaccio D, et al. Amygdala functional connectivity, HPA axis genetic variation, and life stress in children and relations to anxiety and emotion regulation. Journal of Abnormal Psychology. 2015;124(4):817-833.
-
Heim CM, et al. Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis. Frontiers in Psychiatry. 2022.
-
Yao H, et al. Hypothalamus-pituitary-adrenal and gut-brain axes in biological interaction pathway of the depression. Frontiers in Neuroscience. 2025.
-
Vasconcelos M, et al. Stress, hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-gonadal axis, and aggression. PMC. 2025.
-
National Institute of Mental Health. Anxiety Disorders. NIMH. Accessed June 2026.
Frequently Asked Questions
Is anxiety caused by a chemical imbalance?
Anxiety is not caused by a simple chemical imbalance of a single neurotransmitter. It involves dysregulation across multiple interconnected systems: the serotonin system, the GABA inhibitory system, the norepinephrine stress response system, and the HPA axis cortisol pathway. Brain imaging shows structural and functional differences in the amygdala, prefrontal cortex, and hippocampus of people with anxiety disorders. The 'chemical imbalance' framing is an oversimplification, but the biological reality is real and measurable.
Can anxiety be caused by trauma?
Yes. Early life stress and trauma are among the most potent environmental triggers for anxiety disorders. Adversity during development can produce lasting changes in HPA axis function, amygdala reactivity, and prefrontal cortex inhibitory control through epigenetic mechanisms. These changes persist into adulthood, increasing vulnerability to anxiety in response to subsequent stressors. Women who have experienced childhood trauma or adversity have significantly elevated risk of anxiety disorders in adulthood.
Is anxiety hereditary?
Genetic factors account for approximately 30 to 50 percent of anxiety disorder risk, depending on the specific disorder. First-degree relatives of people with anxiety disorders have elevated risk. However, genes are not destiny. Genetic predispositions interact with environmental factors, particularly early life stress and adversity, through gene-environment interactions. Many people with genetic vulnerability never develop a clinical anxiety disorder, and many without obvious family history do.
What is the role of the amygdala in anxiety?
The amygdala evaluates sensory information and initiates fear and threat responses. It operates rapidly, often before conscious awareness, triggering the fight-or-flight cascade. In anxiety disorders, the amygdala shows measurable hyperactivity, producing exaggerated fear responses and heightened sensitivity to ambiguous or neutral stimuli that are not objectively threatening. The prefrontal cortex normally exerts top-down inhibitory control over the amygdala; dysfunction in this regulatory pathway is a core feature of anxiety disorders.
Does diet affect anxiety?
The gut-brain axis is a bidirectional communication network between gut microbiota and the central nervous system. Disruptions in gut microbiota composition have been associated with anxiety and mood disorders through inflammatory pathways and effects on serotonin production, since approximately 90 percent of the body's serotonin is produced in the gut. Highly processed diets, alcohol, and chronic caffeine use can also dysregulate the HPA axis and exacerbate anxiety symptoms. The research is ongoing, but gut health appears to be a meaningful modifiable contributor.
Why does anxiety get worse at night?
Cortisol, the primary stress hormone, follows a circadian rhythm, rising sharply in the early morning and declining through the day. At night, in the absence of external distractions and sensory input, the brain's default mode network becomes more active, which can amplify rumination and threat-monitoring. Disrupted sleep from anxiety and anxiety from disrupted sleep create a reinforcing loop. Anxiety that is reliably worse at night is often linked to HPA axis dysregulation, which can be assessed and addressed clinically.
Mental healthcare should stay with you between appointments.
SiggyMD combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.
Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.